Related Experiment Video

Updated: Jul 7, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Kasabach-Merritt syndrome associated with angiosarcoma of the scalp successfully treated with chemoradiotherapy

Shinichi Imafuku, Chisato Hosokawa, Yoichi Moroi

    Acta Dermato-Venereologica
    |March 4, 2008
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
    07:29

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

    Published on: April 22, 2019

    Related Experiment Videos

    Last Updated: Jul 7, 2026

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
    07:29

    Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

    Published on: April 22, 2019

    Related Concept Videos

    Treatment Resistent Cancers02:56

    Treatment Resistent Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
    Treatment Resistant Cancers02:56

    Treatment Resistant Cancers

    Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

    Articles linked to this work by shared authors, journal, and citation graph.

    Clinical Condition and Management of 114 Mamushi (Gloydius blomhoffii) Bites in a General Hospital in Japan.

    Internal medicine (Tokyo, Japan)·2017

    Evaluation of mapping biopsies for extramammary Paget disease: A retrospective study.

    Journal of the American Academy of Dermatology·2017

    Long-Term Health Effects of PCBs and Related Compounds: A Comparative Analysis of Patients Suffering from Yusho and the General Population.

    Archives of environmental contamination and toxicology·2017

    A case of Basaloid Follicular Hamartoma.

    Fukuoka igaku zasshi = Hukuoka acta medica·2017

    Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2017

    Current state of yusho and prospects for therapeutic strategies.

    Environmental science and pollution research international·2017

    Invisible Challenges of a Visible Disease: A Qualitative Study on Disease-related Impairment, Participation Barriers and Care Experiences in Adults with Ichthyosis.

    Acta dermato-venereologica·2026

    Efficacy and Safety of Delgocitinib and Its Impact on Patient's Perspective for Moderate-to-severe Chronic Hand Eczema in Adults: A 16-week Real-world Prospective Multicentre Study.

    Acta dermato-venereologica·2026

    Corrigendum: Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special Populations.

    Acta dermato-venereologica·2026

    Objectively Measured Photoaging and Skin Cancer in Organ Transplant Recipients.

    Acta dermato-venereologica·2026

    Summary of Best Evidence for Wound Management in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

    Acta dermato-venereologica·2026

    Photodynamic Diagnosis of Actinic Keratosis: A Systematic Review.

    Acta dermato-venereologica·2026

    Generation of hypoimmunogenic cardiomyocytes from human induced pluripotent stem cells with TAPBP knockout.

    iScience·2026

    Design and validation of a GMP-compliant manufacturing platform of extracellular vesicles from mesenchymal stromal cells.

    iScience·2026

    Molecular sterics guide tmRNA translocation on the ribosome.

    bioRxiv : the preprint server for biology·2026

    Allogeneic stem cells transplantation in children, adolescents and young adults previously treated by tisagenlecleucel for B-cell precursor acute lymphoblastic leukemia: a French retrospective SFGM-TC study.

    Transplantation and cellular therapy·2026

    Study on the role of NLRP3 inflammasome in MSC-mediated repair of high-glucose-induced damage to testicular Sertoli cells.

    Reproductive toxicology (Elmsford, N.Y.)·2026

    Beyond the neurological horizon: A metabolic paradigm shift in intravenous iron therapy for restless legs syndrome.

    Sleep medicine·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us